Rematib 15 mg 30 Tablets | Upadacitinib

What is  Rematib 15 mg (upadacitinib)?

Rematib 15 mg (30 tablets) is used to treat moderate to severe rheumatoid arthritis in adult or children above 2 years who have not respond to their tumor necrosis factor (TNF) receptor inhibitor medication. It is also used to treat psoriatic arthritis. Rematib is an orally viable Janus Kinase inhibitor, works by inhibiting Janus Kinases involved in immune mediated inflammatory disease.

Indications for Rematib (upadacitinib)

Rematib (upadacitinib) is indicated to treat various types of autoimmune disease including, Atopic dermatitis, Psoriatic Arthritis, Rheumatoid Arthritis and Alopecia Areata.

Dosage and Administration

Rematib is available as 15 mg extended release(ER) for oral consumption.

Rematib (upadacitinib) to treat Rheumatoid arthritis:

15 mg Rematib daily once in adult patients with or without food as a whole tablet without splitting or crushing it.

Rematib (upadacitinib) to treat Psoriatic arthritis :

15 mg Rematib orally daily once in adult patients with or without food.

Rematib (upadacitinib) to treat Atopic dermatitis:

The recommended dose is 15 mg daily for pediatric patients age 12 years or older than that, at least 40 kg weight. If the therapeutic response is not reached dose can be increased by 30 mg daily once, even after that if therapeutic respond is not received patients should discontinue taking Rematib.

Rematib (upadacitinib) to treat Alopecia Areata:

The initial dose is 30 mg upadacitinib daily by mouth till 12 weeks or until disease progression. Dose can be modified or continue as 30 mg with your doctors’ permission. To treat eczema with upadacitinib initial dose is 30 mg rematib 15mg (upadacitinib) daily by mouth until 8 weeks or disease progression.

Rematib (upadacitinib) to treat Ulcerative Colitis

To treat ulcerative colitis with upadacitinib(rematib) the recommended dose is 45 mg daily by mouth for 8 weeks. If anything severe happen because of taking rematib consider as 30 mg daily or consult with your doctor.

Rematib (upadacitinib) Ankylosing Spondylitis

15 mg upadacitinib daily by mouth who have had an inadequate response or intolerance to ≥1 TNF blockers.

Upadacitinib (Rematib 15 mg) Side Effects

Rematib is a brand name for upadacitinib, a Janus kinase (JAK) inhibitor used to treat conditions like rheumatoid arthritis, atopic dermatitis (eczema), and other inflammatory diseases. Like all medications, Rematib (upadacitinib) can cause side effects. Here are some common and serious side effects associated with its use:

Common Side Effects:

1. Upper respiratory infections (e.g., sinus infections, the common cold)
2. Headache
3. Nausea
4. Increased blood pressure
5. Fatigue or tiredness
6. Acne
7. Elevated liver enzymes (which may indicate liver issues)
8. Diarrhea

Serious Side Effects:

1. Infections:
   • Increased risk of serious infections like tuberculosis, bacterial, fungal, or viral infections (including shingles).
2. Blood Clots:
   • Increased risk of deep vein thrombosis (DVT), pulmonary embolism (PE), and stroke, especially in patients with certain preexisting conditions.
3. Heart Problems:
   • Possible increased risk of heart-related issues, including heart attacks or other heart problems.
4. Cancer:
   • A potential risk for certain types of cancers, such as lymphoma or other malignancies, due to immune system suppression.
5. Liver problems:
   • Signs of liver damage (e.g., yellowing of skin or eyes, dark urine, pain in the upper right part of the stomach) may occur.
6. Low blood cell counts:
   • Can cause low white blood cells (increasing the risk of infection), low red blood cells (anemia), or low platelets (increasing bleeding risk).
7. Gastrointestinal issues:
   • Inflammatory bowel disease (IBD)-like symptoms such as abdominal pain, diarrhea, or blood in the stool.
8. Raised cholesterol levels:
   • Upadacitinib can sometimes cause increases in cholesterol, which may need monitoring over time.

Warnings:

• Not recommended for people with active infections or certain preexisting conditions, such as liver disease or blood disorders.
• Pregnancy and breastfeeding: Should be used with caution in these situations, as safety is not well-established.

Rematib 15 mg (upadacitinib) Price

Rematib 15 mg (upadacitinib) costs $100 for 30 tablets. The price is variable and can be changed at any time. The total price will be counted on including shipping charge. To know the exact price in your location contact with us, and give your address. We will calculate the total cost for rematib 15 mg upadacitinib.

Rematib 15 mg (upadacitinib) for vitiligo treatment

Upadacitinib (rematib) has been approved to treat non-segmental vitiligo patients. To treat non-segmental vitiligo patients with rematib the recommended dose is 30 mg rematib daily by mouth. As it is a potential treatment option for vitiligo take doctor’s permission before taking this medication. You also can try Rutinib Cream (Ruxolitinb) which is also used to treat vitiligo.

Pregnancy and Lactation

Based on animal studies it was found that Rematib can harm fetus in the worm that’s why it is not recommended during pregnancy. Or women should take proper contraception during taking this medication.

In case of lactation it should not be administrated during breast feeding to children.

Storage

Store Rematib below 25 degree C away from direct sunlight and children.

FAQs about Rematib 15 mg 30 Tablets

What is the price of Rematib 15 mg for 30 tablets?

The price of Rematib 15 mg for 30 tablets is $100 excluding shipping charge.

What should I do if I miss a dose of Rematib?

Consult with your doctor immediately, do not try to cover up missing or over dose.

see also Rutinib Cream for atopic dermatitis.